organisation current research and strategies 2011 - 2012 - eortc

organisation current research and strategies 2011 - 2012 - eortc

organisation current research and strategies 2011 - 2012 - eortc

Mechanobiological Strategies to Augment Cancer Treatment

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology

Frontiers Novel Combination Therapies for the Treatment of Bladder Cancer

organisation current research and strategies 2011 - 2012 - eortc

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation - The Lancet Oncology

National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities - The Lancet Oncology

Breast cancer - The Lancet

Genitourinary cancer neoadjuvant therapies: current and future approaches: Trends in Cancer

Descriptive statistics of the EORTC QLQ-C30 and the QLQ-HCC18 and

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder